Skip to main content
. 2014 Jul 3;9(7):e101469. doi: 10.1371/journal.pone.0101469

Figure 3. The expression of HLA-DR, CD80 and CD86 on 16 HBE was assayed by flow cytometry.

Figure 3

A, B: The influence of NS1 on the expression of HLA-DR, CD80 and CD86 on 16 HBE with or without OVA treatment (**P<0.01 versus 16 HBE group; ##P<0.01 versus GFP group; $$P<0.01 versus GFP-NS1 group). C: The influence of NS2 on the expression of HLA-DR, CD80 and CD86 on 16 HBE with or without OVA (**P<0.01 versus 16 HBE group). Data represent Means ± SE of 6 experiments.